UniProt: Q96T66 (NMNA3_HUMAN). HGNC:20989. Gene: NMNAT3. 252 aa. Chromosome 3.
EC 2.7.7.1 (nicotinamide-nucleotide adenylyltransferase) and EC 2.7.7.18
(nicotinate-nucleotide adenylyltransferase).
NMNAT3 is the mitochondrial isoform of nicotinamide/nicotinic acid mononucleotide
adenylyltransferase, one of three human NMNATs (NMNAT1 nuclear, NMNAT2 Golgi/cytosolic,
NMNAT3 mitochondrial). It catalyses the central, shared reaction of NAD+ biosynthesis:
adenylyl transfer from ATP to a pyridine mononucleotide.
Both branches are catalysed with comparable efficiency; NMNAT3 has a notably broad
substrate tolerance among the three isoforms.
[file:human/NMNAT3/NMNAT3-uniprot.txt "Catalyzes the formation of NAD(+) from nicotinamide
mononucleotide (NMN) and ATP (PubMed:16118205, PubMed:17402747, PubMed:26616331). Can also
use the deamidated form; nicotinic acid mononucleotide (NaMN) as substrate with the same
efficiency."]
[file:human/NMNAT3/NMNAT3-uniprot.txt "Nicotinamide mononucleotide adenylyltransferase
(NMNAT) is the central enzyme of"] — from PMID:16118205 abstract.
PMID:16118205 (Berger et al. 2005) PMID:16118205 — establishes NMNAT3 mitochondrial localization
and differential catalytic properties (broad substrate tolerance; can also form NADH directly
from reduced NMN). Source of the GO:0000309, GO:0004515 (IDA) and GO:0005739 (IDA/EXP)
annotations.
PMID:17402747 (Sorci et al. 2007) PMID:17402747 and PMID:17402747. Full initial-rate kinetics; Mg2+ cofactor (per UniProt);
distinctive substrate binding order for NMNAT3. Source of GO:0000309, GO:0004515 (EXP).
PMID:12574164 (Zhang et al. 2003) PMID:12574164 and PMID:12574164. 1.9 Å X-ray structures (PDB 1NUP-1NUU) in complex with NMN, NAD,
ATP analog; homotetramer (SUBUNIT: Homotetramer, PubMed:12574164). Source of GO:0005739 (EXP)
localization.
Mitochondrion / mitochondrial matrix. UniProt SUBCELLULAR LOCATION:
[file:human/NMNAT3/NMNAT3-uniprot.txt "SUBCELLULAR LOCATION: Mitochondrion"].
Note some studies (Zhang 2003; Reactome R-HSA-200474) report both cytosolic and mitochondrial
pools; Reactome annotates the mitochondrial form. HTP mito-proteome (PMID:34800366) and HPA
immunofluorescence (GO_REF:0000052) corroborate mitochondrial localization.
GO:0006457 (protein folding, IDA) and GO:0044183 (protein folding chaperone, IDA) are annotated
to human NMNAT3 citing PMID:18344983 (Zhai et al. 2008, Nature). That paper demonstrates the
chaperone function in Drosophila NMNAT (DmNMNAT):
PMID:18344983. It does not assay
human NMNAT3 chaperone activity specifically. This is a family-/similarity-level attribution.
The chaperone activity is a real, well-documented NMNAT function in Drosophila, but for the
human mitochondrial NMNAT3 isoform it is not directly demonstrated and is peripheral to the
core mitochondrial NAD+-synthesis function. Marked KEEP_AS_NON_CORE (experimental IDA; do not
remove).
PMID:26616331 (Ruan et al. 2015, Nat Commun) is about Drosophila Nmnat splice variants; it
mentions human NMNAT3 splice variants only in passing
PMID:26616331. It is cited on a GO:0000309 (NMNAT activity, IDA) annotation. NMNAT activity is
unquestionably correct for human NMNAT3 (see 16118205, 17402747), so retained; the citation is
weaker than the two primary human enzymology papers.
Core MF: the two catalytic activities directly demonstrated by human enzymology:
- GO:0000309 nicotinamide-nucleotide adenylyltransferase activity (EC 2.7.7.1) — NMN + ATP -> NAD+
- GO:0004515 nicotinate-nucleotide adenylyltransferase activity (EC 2.7.7.18) — NaMN + ATP -> NaAD
Both are strictly supported by IDA/EXP (16118205, 17402747) and match the UniProt CATALYTIC
ACTIVITY / EC assignments. Broad parents GO:0016779 (nucleotidyltransferase activity) and
GO:0003824 (catalytic activity) are IEA over-generalizations.
ATP binding (GO:0005524) appears in the UniProt DR GO block (IEA UniProtKB-KW) but is NOT in the
GOA TSV rows seeded into the review, so it is not reviewed as an existing annotation.
NMNAT3 is a mitochondrial NAD+ biosynthetic enzyme supplying the mitochondrial NAD+/NADH pool by
adenylylating NMN (-> NAD+) and NaMN (-> NaAD), the final shared step of both the de novo/
Preiss-Handler and salvage routes to NAD+.